ChinaBio® Partnering Forum grants the global biopharma community the largest network of potential partners to accelerate cross-border strategies and expand your reach in to the China life science market.

The Startup Spotlight is back in Shanghai following its successful ChinaBio® Partnering Forum launch in 2023.

This fast-paced pitch competition features the most innovative startup biotech companies around today. In an energizing start to Day Two, our live competition will give a group of hand selected startups the opportunity to pitch in front of the China Bio audience and our panel of esteemed judges.

The winner will receive an exciting prize to help them on their journey to success!

Keynote panel: Achieving renewed success in China thorough increased collaboration, enhanced asset valuation and international reach

The distinguished opening keynote panel will consist of influential pharma dealmakers leading the path to development, funding, and partnerships in a flourishing Asian market.

CEO Perspective: China’s current and future strategies for pipeline expansion and enduring international partnerships

CEO’s of leading innovative companies will come together to share their strategies for expanding products and markets through successful global collaborations. They will also discuss how multi-national companies are tapping into China’s research potential via M&A.

Healthy China 2030: Examining market access challenges, strategies and the role of multi-national companies

This session will address the specific impacts of new regulations, provide market access updates, and showcase key business strategies, partnerships, and investment.

Key trends in cross border investment: From local discovery to global innovation

This panel will question the main drivers in cross-border investments and their impact on investments. How much will global economic uncertainty play a role?

How quickly could China’s ability to build state-of-the-art AI systems transform global drug discovery?

Assessing the real potential of integrating AI into China’s drug development lifecycle: What does this mean in terms of faster drug discovery, clinical trials and decision-making?

Biotech IPO in China: The latest trends, predictions, and emerging investment strategies

Join our investment panel as they share their experiences of navigating the layers of complexity involved in the decision-making process for Biotech IPOs in China.